Our objective was to investigate variables which, although occurring during the acute period,
could influence the medium (1st year) and long-term (6th year) survival of infarcted patients …

Because the reestablishment of coronary blood flow is believed to be central to the benefit of
thrombolytic therapy, measurements of reperfusion (ie, angiography before and after …

Thrombotic occlusion of an epicardial coronary artery has been implicated as a potential
mechanism involved in acute myocardial infarction since as early as 1910, w1 and became …

ISIS-2 reported a 16% reduction in the 5 week vascular mortality rate (18.2% versus 21.6%)
in the streptokinase group> 70 years of age at entry, a 26% reduction (10.6% versus 14.4%) …

Thrombotic complications of cardiovascular disease are a main cause of death and disability
and, consequently, thrombolysis could favorably influence the outcome of such life …

Streptokinase. APSAC, and tPA clearly reduce mortality in acute myocardial infarction. tPA is
definitely superior at recanalization: it does it faster and more effectively in the first 1-2 h after …

More than 200,000 people have been enrolled into clinical trials examing different
reperfusion strategies for patients with acute myocardial infarction. Each year approximately …

OBJECTIVES.: This study attempted to determine which lesion characteristics are
associated with reocclusion by 18 to 36 h. BACKGROUND.: Reocclusion of the infarct …

Thrombolytic dissolution of coronary artery thrombus has added new dimensions to early
myocardial infarction treatment. Reperfusion via streptokinase infusion has been shown to …